Notable Research Findings

The most groundbreaking individual studies from the latest supplement and nutrition research — in plain language, with the evidence caveats built in. Research signals worth knowing about, not health advice.

A sesame oil dab lowered phlebitis severity more than a common herbal alternative in 108 patients on an IV heart drug — but the trial was open-label, so patients and nurses knew who got what.
- 2026-03-18
- RCT
- n = 108
- Explore (New York, N.Y.)
This is a single, unblinded trial in a hospital setting, so while the effect was large and statistically significant, the result needs replication before it applies to everyday use — treat it as an intriguing signal, not settled science.
SurprisingSesame for Reduced Phlebitis Severity
In a 12-month trial, adding peony extract to standard therapy nearly doubled the odds of complete remission in a painful oral condition — but the study was open-label, so expectations need tempering.
- 2026-02
- RCT
- n = 448
- Phytomedicine : international journal of phytotherapy and phytopharmacology
This is the first large RCT on peony for oral lichen planus, and the effect is unusually large (53.9% vs. 34.4% complete response), but because neither patients nor doctors knew who got the supplement, the real-world benefit could be smaller — and the results only apply to people with this specific, hard-to-treat condition.
Big effectPeony for Improved Complete Response Rate
Vitamin K as an add-on therapy slashed liver cancer recurrence risk by 74% in a meta-analysis — but only in patients with advanced tumors who couldn't have surgery.
- 2026-03-18
- Systematic Review
- n = 688
- Frontiers in oncology
This is an unusually large effect from a systematic review of 688 patients, but it's among the first indexed studies on vitamin K for this specific use, so the finding needs replication before you'd act on it.
Big effectVitamin K for Reduced Recurrence Risk
A probiotic improved quality of life in children with drug-resistant epilepsy — but the trial was tiny and the population highly specific.
- 2026-03-01
- RCT
- n = 60
- Pharmacotherapy
This small, 6‑month trial suggests Lactobacillus acidophilus may help children whose epilepsy hasn’t responded to standard drugs, but with only 60 participants and no replication yet, the finding is intriguing rather than actionable for the general public.
SurprisingLactobacillus acidophilus for Improved Quality of Life
Inhaled Clostridium butyricum slashed pneumonia risk from 46% to 2% in a 310-person trial — but the delivery method (nebulization) is far from everyday use.
- 2026-01-24
- RCT
- n = 310
- Applied microbiology and biotechnology
This is a striking early signal for a novel probiotic delivery route, but it comes from a single study — so treat the size of the effect as promising, not settled.
Big effectClostridium butyricum for Reduced Incidence of Bacterial Pneumonia
Pregnant women taking 250 µg/day of B12 had infants scoring 7.8 centiles higher on a mental development test — but only compared with a 50 µg dose, and the effect may not apply outside vegetarian populations.
- 2026-03
- RCT
- n = 276
- BMJ paediatrics open
This is one of the first rigorous trials to link prenatal B12 dose size to infant neurodevelopment, but with no placebo group and a single, specific population (vegetarian mothers), the finding is promising but far from settled.
Big effectVitamin B12 for Improved Mental Developmental Quotient
A four-week trial found 6000 IU/day of vitamin D3 boosted blood levels in MMA athletes — but 3500 IU/day did the same for untrained men, while failing in the athletes.
- 2026-03-26
- RCT
- Nutrients
This pilot study suggests that training status, not just baseline deficiency, may determine how much vitamin D3 you need to raise your levels — a useful reminder that one-size-fits-all dosing advice may miss the mark, though the small sample and short duration mean the pattern is far from settled.
SurprisingVitamin D3 for Increased Vitamin D Level
A meta-analysis of 677 people found vitamin D failed to significantly reduce tuberculosis infection risk — the odds ratio was 0.95, a null result with a confidence interval spanning from a 21% reduction to a 14% increase.
- 2025-07-02
- Meta-Analysis
- n = 677
- Biomolecules & biomedicine
This is one of the first systematic looks at vitamin D for TB prevention, and its clear null finding contests the idea that supplementation meaningfully protects against infection — but because the body of evidence is still small, the picture is far from settled.
Myth-busterVitamin D for Reduced Tuberculosis Infection
In a 120-patient trial, N-acetyl cysteine (1200 mg/day) failed to significantly reduce contrast-induced kidney injury — while a statin cut the rate from 32.5% to 12.5%.
- 2026-02-17
- RCT
- n = 120
- Clinical drug investigation
This single RCT challenges the popular notion that NAC is a reliable protector against kidney damage from contrast dye, but with only 120 patients and a specific Egyptian clinical population, the picture is far from settled — treat this as a provocative data point, not a verdict.
Myth-busterN-Acetyl Cysteine for Reduced Contrast-Induced Acute Kidney Injury
Peppermint oil dropped systolic blood pressure by 8.5 mmHg in a 20-day trial — but diastolic pressure, heart rate, and mood stayed flat.
- 2026-04-23
- RCT
- n = 40
- PloS one
This small, short study found a surprisingly strong effect on one specific blood pressure number, but it’s the first of its kind, and none of the other cardiometabolic markers budged — so the picture is intriguing but far from conclusive.
SurprisingPeppermint for Reduced Blood Pressure
Saffron supplementation linked to a moderate reduction in systolic blood pressure in people with diabetes and prediabetes — but the study found no effect on diastolic pressure, and the effect size is not clinically important.
- 2025-03
- Meta-Analysis
- Prostaglandins & other lipid mediators
This is the first solid evidence for saffron on blood pressure in this clinical group, but because it's a single, early meta-analysis with a modest effect that wasn't mirrored in other key outcomes, the finding should be seen as intriguing but far from proven.
New evidenceSaffron for Reduced Systolic Blood Pressure
Vitamin E for Friedreich ataxia? A meta-analysis of 7 trials found no benefit on ataxia scores after 12 months — and the same went for other drugs tested.
- 2026-05-12
- Meta-Analysis
- n = 574
- The Cochrane database of systematic reviews
This null result challenges the common assumption that vitamin E can slow or reverse ataxia in Friedreich's disease, but the evidence is moderate-certainty and based on only 513 participants across seven studies — so the picture is contested, not settled.
Myth-busterVitamin E for Improved Ataxia Rating Scale Score
N-Acetylcysteine failed to cut alcohol cravings in a systematic review of 566 patients — the result was statistically indistinguishable from placebo.
- 2026-05-11
- Systematic Review
- n = 566
- BMC psychiatry
This is one of the first systematic reviews on NAC for alcohol craving, and its null result challenges the popular notion that NAC is a reliable anti-craving supplement — but the picture is far from settled, since the same analysis hinted at a possible effect on PTSD symptoms that deserves further study.
Myth-busterN-Acetyl Cysteine for Reduced Alcohol Craving
Vitamin D cut psoriasis severity by 3.3 points in a meta-analysis — but 2 of the 3 studies that went into it found no benefit.
- 2025-12-11
- Systematic Review
- n = 463
- Frontiers in nutrition
This isn't a breakthrough — it's a provocative signal from a small, low-certainty evidence base that leaves the overall picture genuinely mixed.
Myth-busterVitamin D for Reduced Psoriasis Area and Severity Index
Pre-workout protein edged out post-workout for leg press strength in a meta-analysis — but only just (SMD: 0.70; p = 0.048; I² = 31%).
- 2025-06-21
- Meta-Analysis
- Nutrients
This is the first meta-analysis to directly compare before versus after exercise protein timing for strength, and while it found a modest benefit for leg press, the effect was borderline significant and didn't replicate across chest press or lean mass gains — so it's intriguing, but too early to rewrite your routine around it.
New evidenceProtein for Improved Leg Press Strength
Vitamin D for at least three months lowered thyroid antibodies in autoimmune patients — but the benefit may depend on starting levels.
- 2025-06-16
- Meta-Analysis
- n = 577
- PeerJ
This meta-analysis is the first to pool evidence on vitamin D and thyroid antibodies, but with only 577 patients and a wide range of doses, the results are preliminary and need replication.
New evidenceVitamin D for Reduced Anti-Thyroid Peroxidase Antibody
Tribulus raised erectile function scores by about 3 points on a 25-point scale in a meta-analysis — but the same review found it did not budge testosterone levels at all.
- 2025-05-13
- Meta-Analysis
- International journal of impotence research
This is a small, low-strength body of evidence (3 studies, 2 positive, 1 neutral) from a clinical population of men with erectile dysfunction, so the modest improvement may not apply to healthy men or general supplement users.
TrendingTribulus for Improved Erectile Function
L-carnitine supplements didn't lower total cholesterol in a meta-analysis of 28 trials — but the patients were all on dialysis
- 2024-12-02
- Systematic Review
- n = 28
- Frontiers in medicine
This contradicts the popular notion that L-carnitine helps manage cholesterol, but only in a specific clinical group. Since this is among the first indexed studies on this pairing, the picture is far from settled for healthy people.
Myth-busterL-Carnitine for Reduced Total Cholesterol Levels
A double-blind trial of 500 mg Haritaki twice daily for angina found no improvement in symptoms — and no effect on cholesterol, inflammation, or quality of life either.
- 2026-01-24
- RCT
- n = 100
- BMC complementary medicine and therapies
This small but well-designed study contradicts the popular belief that Haritaki helps heart conditions, but since it's one of the first trials on this pairing, the verdict is far from final.
Myth-busterHaritaki for Improved Angina Symptom
A meta-analysis of 773 patients found NAC linked to a 34% lower risk of post-ERCP pancreatitis — but the result wasn't statistically significant, and it didn't reduce severity either.
- 2025-11-04
- Meta-Analysis
- n = 773
- BMC gastroenterology
This is among the first indexed studies on NAC for this specific clinical setting, so the evidence is too weak to support routine use; the null result and lack of effect on severity mean the popular notion that NAC prevents pancreatitis isn't backed by this analysis.
Myth-busterN-Acetyl Cysteine for Reduced Incidence of Post-ERCP Pancreatitis
A small trial in elite wrestlers linked 3 mg/kg of L-theanine (paired with caffeine) to lower trait anxiety — but seven other performance and cognitive measures showed no significant effect from the combination.
- 2025-09-22
- RCT
- Journal of the International Society of Sports Nutrition
This is an early, exploratory finding in a very specific group of athletes, so don’t assume the anxiety benefit or the performance edge applies to you — especially since the same study found zero benefit on grip strength, vertical jump, reaction time, and four other outcomes.
SurprisingL-Theanine for Reduced Trait Anxiety
Lactobacillus therapy nearly doubled the odds of cervical lesion resolution in women with HPV — a meta-analysis of five small trials, none of which specified the dose used.
- 2025-08
- Meta-Analysis
- n = 326
- The Journal of international medical research
This is an unusually large effect from a well-conducted meta-analysis, but it's based on just 326 participants across five studies, and this pairing has almost no prior indexed research — so the finding is promising but far from settled.
Big effectLactobacillus for Resolved Cervical Lesion
A probiotic slashed C. diff recurrence to 1.7% versus 13.1% when added to standard antibiotics — but the benefit was limited to mild-to-moderate cases and several other outcomes (diarrhea, gut microbiome, functional ability) showed no improvement.
- 2025-06-02
- RCT
- Scientific reports
This is an unusually large effect from a single, well-controlled trial, but it's one of the first studies on this specific combination, so the finding needs replication before you can count on it.
Big effectsaccharomyces boulardii for Reduced Recurrence Rate
A meta-analysis found that soy consumption (as miso) showed no statistically significant link to all-cause mortality — despite the broader fermented food category being tied to a lower risk.
- 2026-02-26
- Systematic Review
- Frontiers in nutrition
This null finding challenges any assumption that soy-based fermented foods like miso automatically carry the same mortality benefits as yogurt, cheese, or chocolate, but it’s one of the first systematic reviews on this specific pairing, so the picture isn’t settled yet.
Myth-busterSoy for Reduced All-Cause Mortality
A meta-analysis of 40 trials found soy isoflavones didn't significantly thicken the endometrium — but the result fell just short of statistical significance (p=0.059).
- 2025-01
- Meta-Analysis
- n = 3,285
- Advances in nutrition (Bethesda, Md.)
This contradicts the widespread belief that soy isoflavones act like estrogen in the body, but because the finding is on the edge of significance and this is among the first large-scale analyses of its kind, it doesn't settle the debate — it shifts the burden of proof.
Myth-busterSoy for Reduced Endometrial Thickness
Chromium cut triglycerides sharply in women with PCOS — a large effect in a clinical group, not a general population.
- 2025-10
- Meta-Analysis
- n = 683
- Endocrinologia, diabetes y nutricion
This is early evidence from a well-conducted meta-analysis, but the result is specific to women with PCOS; it does not yet tell us whether the same benefit would appear in healthy people or other conditions.
Big effectChromium for Reduced Triglyceride Levels
A meta-analysis found vitamin K intake linked to a 17% lower fracture risk — but the confidence interval crossed 1.0, meaning the result wasn't statistically significant.
- 2025-09-09
- Meta-Analysis
- n = 776
- Current rheumatology reviews
This early meta-analysis doesn't confirm the popular belief that vitamin K protects bones; the null result and lack of effect on hip fractures mean the picture is still contested, not settled.
Myth-busterVitamin K for Reduced Fracture Risk
Vitamin D halved the risk of post-surgery atrial fibrillation in heart bypass patients who were truly deficient — but showed no benefit for those with milder insufficiency.
- 2025-10-17
- Meta-Analysis
- n = 694
- BMC cardiovascular disorders
This is a large, precisely measured effect in a specific clinical population, but it's one of the first studies on this pairing. The finding likely applies only to vitamin D deficient individuals undergoing coronary artery bypass grafting — not to the general public or even to heart surgery patients with normal vitamin D levels. Notably, the same meta-analysis found the supplement did not shorten hospital stays or reduce time on a ventilator, suggesting the benefit is narrow.
Big effectVitamin D for Reduced Postoperative Atrial Fibrillation
Stroke survivors with lower serum albumin showed a clear cognitive decline difference — a meta-analysis of 9 studies found the gap averaged 3.85 units, but the link is only in a clinical population and hasn't been tested in healthy adults.
- 2025-08-13
- Systematic Review
- Frontiers in neurology
This is the first systematic review to tie low albumin to post-stroke cognitive impairment, but with no data on healthy people and no dose specified, it's an early clue — not a conclusion you can act on yet.
New evidenceAlbumin for Reduced Cognitive Impairment
A mouse study found a new Lactobacillus paracasei strain lowered three inflammatory markers — but the results come from animals, not humans.
- 2026-01-29
- Meta-Analysis
- Frontiers in microbiology
This is early animal research on a specific strain, so while the anti-inflammatory signal is promising, it's far from being a proven supplement for people with colitis.
TrendingLactobacillus paracasei for Reduced Inflammation